Trial intelligence / Profile preview

Comparison of Low-Dose and High-Dose Melatonin for Prevention of Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery

TCTR20250424001Phase 3Completed

Sponsor
Pranangklao Hospital
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in postoperative delirium (POD), sponsored by Pranangklao Hospital. Started Jun 2025; status: completed.

02

Drugs

melatonin
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on TCTR20250424001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250424001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call